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19th CardioVascular Summit: TCTAP 2014generic enoxaparin group. Hence, be careful to use generic enoxaparin in patients who
had percutaneous coronary intervention.Basic Science, Animal Models and Preclinical Studies
(TCTAP A-146 to TCTAP A-149)
TCTAP A-146
MicroRNA-21 Expression and its Association with Leukocytes Inﬁltration on the
Early Phase of Coronary Microembolization
Zhangwei Chen, Jianying Ma, Juying Qian, Shufu Chang, Aijun Sun, Yunzeng Zou,
Junbo Ge
Zhongshan hospital, Shanghai, China
Background: MicroRNAs are small non-coding RNAs that regulate gene expression
at the post-transcriptional level by either degradation or translational repression of a
target mRNA. It has been demonstrated that miR-21 plays a critical role on inﬂam-
matory response after acute myocardial infarction. However, it is unknown about
myocardial expression of miR-21 after coronary microembolization (CME) in mini-
pigs.
Methods: Ten mini-pigs were enroll in this study, including sham-operation group
(n¼4) and CME group (n¼6). Troponin T and interleukin-6 (IL-6) were detected on
baseline, 6 hour and 7 days after CME. Myocardial expressions of miR-21 were
detected by Realtime-PCR method. Myocardium specimens were embedded in
parafﬁn for hematoxylin and eosin (HE) staining, while number of leukocytes inﬁl-
tration were analyzed by Leica DFC 320 digital soft.
Results: Compared with sham-operation group, serum level of troponin T and IL-6
were increased signiﬁcantly after 6 hours in CME group (Troponin T: 0.6420.239
vs. 0.020.01 ng/ml, P<0.05; IL-6: 140.730.8 vs. 35.421.4 pg/ml, P<0.05).
Leukocyte inﬁltration on microembolization associated myocardium was also
increased markedly after CME. We found that myocardial expression of miR-21 was
increased signiﬁcantly at 7-day after CME (CME vs. sham: 3.721.51, P¼0.033),
which also had a positive relation (r¼0.636, P¼0.046) with average number of leu-
kocytes inﬁltration on microembolization area.
Conclusion: Myocardial miR-21 expression was increased after coronary micro-
embolization, which could be involved in the process of leukocytes inﬁltration.
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Background: In contrast to cardiomyocytes, autophagy in cardiac microvascular
endothelial cells (CMECs) during ischemia/reperfusion (I/R) injury has not been fully
investigated. Tongxinluo (TXL), which is a traditional Chinese medicine formulation
consists of extractions or powders from Radix ginseng, Buthus martensi, Hirudo,
Eupolyphaga seu steleophaga, Scolopendra subspinipes, Periostracum cicadae, Ra-
dix paeoniae rubra, Semen ziziphi spinosae, Lignum dalbergiae odoriferae, Lignum
santali albi, and Borneolum syntheticum, was previously demonstrated to be vascular
protective.This study was designed to elucidate the role of autophagy and its regu-
latory mechanisms by TXL in CMECs subjected to I/R injury.
Methods: CMECs were exposed to varying concentrations of TXL solution for 30
min and subjected to hypoxia/reoxygenation (H/R) each for 2 h to determine the
optimal working concentration. The autophagy inhibitor 3-methyladenine (3-MA), the
autophagy promoter rapamycin, and the MEK inhibitor PD98059 were used to further
investigate the role and the modulatory mechanism of autophagy in CMECs.
Results: The results indicated that H/R signiﬁcantly induced autophagy, as identiﬁed
by an increased number of monodansylcadaverine (MDC)-positive CMECs, increased
autophagosome formation, and a higher type II/type I of light chain 3 (LC3-II/LC3-I)
ratio (p < 0.05), but not Beclin-1 expression. The inhibition of autophagy using 3-MA
was found to be proapoptotic whereas the induction of autophagy by rapamycin was
antiapoptotic, which was reﬂected by index such as ﬂowcytometric apoptotic rates,
expression of Bcl, Bax, and Cytochrome c (p < 0.05). TXL enhanced autophagy and
decreased apoptosis in a dose-dependent manner. TXL reached its largest anti-
apoptotic effect in CMECs at 800 mg/mL (MeanOSEM, 9.92O0.49% in the 800 mg/
mL TXL group vs. 21.04O1.11% in the H/R group, p < 0.05), and MDC-positive cell
rate of the 800 mg/mL TXL group was signiﬁcantly higher than that of the H/R group
(p < 0.05). 3-MA attenuated the TXL-promoted autophagy and antiapoptotic effects
(p < 0.05), whereas rapamycin failed to cause additional effects in comparison to TXL
alone. TXL upregulated the phosphorylation of MEK and ERK, but ERK phos-
phorylation was abrogated by PD98059, which also decreased autophagy and
increased apoptosis in comparison to TXL alone.S42 JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAPConclusion: These results suggest that autophagy is a protective mechanism in
CMECs subjected to ischemia/reperfusion injury and that TXL can promote auto-
phagy via activation of the MEK/ERK pathway.
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Left Ventricular Remodeling with Preserved Function After Coronary
Microembolization: The Effect of Methylprednisolone
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Background: The objective of this study was to evaluate changes in left ventricular
ejection fraction (LVEF) and left ventricular remodeling after coronary micro-
embolization (CME) and to investigate the effects of methylprednisolone (MTP) on
these processes.
Methods: CME was induced by injection of microspheres (42 mm Dynospheres) into
left anterior descending artery of mini swine. The animals were divided into two
groups. Group 1 (n¼9) received 120,000 microspheres and Group 2 (n¼7) received
120,000 microspheres following intravenous administration of 30 mg/kg MTP.
Contrast enhanced MRI was performed at baseline, 6 h after intervention and 1
week later.
Results: In Group 1, LVEFwas signiﬁcantly decreased at 6 h but recovered 1week This
was accompanied by continuing left ventricular remodeling. In Group 2, LVEF
remained unchanged at all assessment times. LVEF measured at 6th hour and at one
week after CME in group 1 and group 2 was 0.390.06 and 0.440.04, and 0.440.04
and 0.480.03 respectively (Both P¼NS). Hyperenchancement at the anterior wall of
the left ventricle was shown by MRI at 6 h in Group 1 but not in Group 2. The hyper-
enhanced area in Group 1 was 7.771.49% of left ventricular mass.
Conclusion: The consequence of CME is left ventricular dilation with preserved
LVEF. Pretreatment with MTP appears to have a cardioprotective effect on left
ventricular remodeling.
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Background: Increased excretion of albumin in urine is an established risk factor for
mortality, cardiovascular events, and adverse renal outcomes in the general popula-
tion. The mechanism underlying albuminuria in patients with HF without DM and
HTN is not known. It may be due to renal congestion or hemodynamic disturbance.
The prevalence and prognostic importance of elevated urinary albumin creatinine
ratio in heart failure are not known. We aimed to study the prognostic importance
of albumin / creatininee ratio in non-diabeticpatients with systolic heart failure.
Methods: 50 patients diagnosed as systolic heart failure with evidence of LV systolic
dysfunction (LV ejection fraction<40%) by echocardiographywere recruited fromNasr
City insurance hospital cardiology department from October 2011 till December 2011
and were followed up till june 2012. Patients were subjected to full history taking,
detailed clinical examination, echocardiography, assessment of serum creatininee and
Urinary albumin creatininee ratio. Patients with pure diastolic dysfunction, patients who
suffered from another serious disease with a poor prognosis, abnormal kidney functions
(creat> 1.5 mg/dl & e GFR < 60ml/min), diabetes were excluded. Patients were fol-
lowed up after six months for echocardiography, Urinary albumin creatininee ratio,
kidney functions and clinical follow up mortality and morbidity,readmission either due
to heart failure or due to occurrence of complications such as ventricular tachycardia,AF,
cerebrovascular strokes, anemias, development of renal or hepatic impairment, devel-
opment of electrolyte imbalance and need for interventions, ICD or multiple pacing.
Results: Patients were divided into three groups according to their base line urinary
albumin creatinine ratio, as group I normo-albuminuric where urinary albumin
creatinine ratio <2.5 mg/mmol in men and <3.5 mg/mmol in women, group II micro-
albuminuric where urinary albumin creatinine ratio 2.5 to 25.0 mg/mmol in men and
3.5 to 25.0 mg/mmol in women, group III urinary albumin creatinine ratio > 25.0 mg/
mmol in men and women.
There were no signiﬁcant changes among the three groups regarding heart rate,
systolic blood pressure and diastolic blood pressure, medical history, and medications.
A signiﬁcant positive relation was found between the 3 groups as regards the event
rate of MACE as group III had the higher urinary albumin creatinine ratio.
NYHA class was signiﬁcantly worse in group III which had more elevated urinary
albumin creatinine ratio.
Follow up serum creatininee was signiﬁcantly higher and ejection fraction was
signiﬁcantly lower in groups II, III than in group I. And all the three groups showed
signiﬁcant increase in urinary albumin creatinine ratio.
The cutoff value is > 2.26 the value above which we have to give more attention to
patient’s clinical status and pay more attention to treatment compliance and optimi-
zation of medical treatment, urinary albumin creatinine ratio above this value
considered of more risk to develop cardiovascular and renal complications in non
diabetic patients with sensitivity of 100% and speciﬁcity 92.6% where positive pre-
dictive value 92% and negative predictive value 100%.
Conclusion: Increasing urinary albumin creatinine ratio was associated with an
increased hazard of adverse clinical outcomes, showing that urinary albumin excretion
represents a continuous measure of risk.Abstracts/POSTER/Basic Science, Animal Models and Preclinical Studies
